Skip to content

Enlighten Study: The EV-ICD Post Approval Registry

Tachycardia | Ventricular Arrhythmia

Medtronic is sponsoring Enlighten: The EV-ICD Post Approval Registry, to further confirm safety and effectiveness of EV-ICD in routine clinical practice, following commercial release of EV-ICD devices.

null

Conditions de participation

  • Sexe:

    ALL

  • Âges admissibles:

    0 and up

Critères de participation

Inclusion Criteria:

* Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements
* Patient is intended to receive or be treated with a EV-ICD device System and must be enrolled prior to the EV-ICD device implant procedure

Exclusion Criteria:

* Patient who is, or is expected to be, inaccessible for follow-up
* Patient is excluded by local local law
* Patient is currently enrolled or plans to enroll in any concurrent drug and/or device study that may confound the PSR results

Lieu de l'étude

Institut Universitaire de Cardiologie et de Pneumo
Institut Universitaire de Cardiologie et de Pneumo
Québec, Quebec
Canada

Contactez l'équipe d'étude

Montreal Heart Institute
Montreal Heart Institute
Montréal, Quebec
Canada

Contactez l'équipe d'étude

University Of Calgary
University Of Calgary
Calgary, Alberta
Canada

Contactez l'équipe d'étude

Étude parrainée par
Medtronic
Participants recherchés
Plus d'informations
ID de l'étude: NCT06048731